|
ARAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.164400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.335570E-02 |
| Normal-vs-Stage2 |
2.226800E-01 |
| Normal-vs-Stage3 |
5.196200E-01 |
| Normal-vs-Stage4 |
7.225000E-01 |
| Stage1-vs-Stage2 |
6.461400E-01 |
| Stage1-vs-Stage3 |
4.161800E-03 |
| Stage1-vs-Stage4 |
5.697000E-01 |
| Stage2-vs-Stage3 |
9.021800E-02 |
| Stage2-vs-Stage4 |
7.303200E-01 |
| Stage3-vs-Stage4 |
5.527800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.145900E-02 |
| Normal-vs-AfricanAmerican |
2.202100E-02 |
| Normal-vs-Asian |
7.767400E-01 |
| Caucasian-vs-AfricanAmerican |
4.813000E-01 |
| Caucasian-vs-Asian |
1.356830E-01 |
| AfricanAmerican-vs-Asian |
3.077200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.513700E-02 |
| Normal-vs-Female |
1.259760E-02 |
| Male-vs-Female |
2.732000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.522600E-01 |
| Normal-vs-Extreme_Weight |
1.468640E-01 |
| Normal-vs-Obese |
7.364300E-03 |
| Normal-vs-Extreme_Obese |
8.140600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.040600E-01 |
| Normal_Weight-vs-Obese |
1.045190E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.112800E-01 |
| Extreme_Weight-vs-Obese |
3.024000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.531600E-01 |
| Obese-vs-Extreme_Obese |
1.412640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.272800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.581900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.915600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.585600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.180400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.299000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.285800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.022800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.823500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.571800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.202500E-03 |
| Normal-VS-Type2 PRCC |
7.880000E-01 |
| Normal-VS-KIRP CIMP |
7.429600E-01 |
| Normal-VS-Unclassified PRCC |
2.377500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.104700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.260200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.632600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.089800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.666440E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.251000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.974800E-01 |
| Normal-vs-N1 |
8.369000E-01 |
| Normal-vs-N2 |
8.203400E-01 |
| N0-vs-N1 |
6.074400E-01 |
| N0-vs-N2 |
7.638200E-01 |
| N1-vs-N2 |
7.680200E-01 |
|
|
